We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$557M
AUM Growth
+$8.06M
Cap. Flow
-$17.4M
Cap. Flow %
-3.12%
Top 10 Hldgs %
15.98%
Holding
514
New
65
Increased
139
Reduced
63
Closed
62

Top Buys

Rank Stock Value
1
OVID icon
Ovid Therapeutics
OVID
+$3.98M
2
AMRX icon
Amneal Pharmaceuticals
AMRX
+$2.56M
3
SIGA icon
SIGA Technologies
SIGA
+$2.52M
4
III icon
Information Services Group
III
+$1.69M
5
RVI
Retail Value Inc. Common Shares
RVI
+$1.67M

Top Sells

Rank Stock Value
1
ACH
Accendra Health
ACH
+$5.72M
2
UCTT
Ultra Clean Holdings
UCTT
+$2.82M
3
MITK icon
Mitek Systems
MITK
+$2.11M
4
BLDR icon
Builders FirstSource
BLDR
+$2.1M
5
MEDP icon
Medpace
MEDP
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Industrials 16.1%
3 Technology 15.87%
4 Financials 14.48%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBOE icon
376
Cboe Global Markets
CBOE
$32.2B
$195K 0.04%
1,635
+373
+30% +$40.9K
VRTX icon
377
Vertex Pharmaceuticals
VRTX
$123B
$186K 0.03%
924
– –
DGX icon
378
Quest Diagnostics
DGX
$26B
$184K 0.03%
1,397
+319
+30% +$41.8K
AXTA icon
379
Axalta
AXTA
$7.45B
$182K 0.03%
5,970
+1,930
+48% +$61.1K
RRX icon
380
Regal Rexnord
RRX
$12.5B
$182K 0.03%
1,366
– –
TECH icon
381
Bio-Techne
TECH
$11.2B
$182K 0.03%
1,620
– –
SBCF icon
382
Seacoast Banking Corp of Florida
SBCF
$3.32B
$181K 0.03%
5,300
-13,703
-72% -$500K
NTAP icon
383
NetApp
NTAP
$33.9B
$176K 0.03%
2,151
+491
+30% +$38.4K
TSN icon
384
Tyson Foods
TSN
$21.5B
$170K 0.03%
2,310
– –
KSS icon
385
Kohl's
KSS
$2.16B
$166K 0.03%
3,017
– –
HSIC icon
386
Henry Schein
HSIC
$9.78B
$164K 0.03%
2,212
– –
ENTG icon
387
Entegris
ENTG
$16.3B
$160K 0.03%
+1,301
New +$149K
CBT icon
388
Cabot Corp
CBT
$4.72B
$153K 0.03%
2,689
+614
+30% +$36.1K
RM icon
389
Regional Management Corp
RM
$390M
$151K 0.03%
3,246
– –
LSTR icon
390
Landstar System
LSTR
$6.03B
$146K 0.03%
921
– –
EBMT icon
391
Eagle Bancorp Montana
EBMT
$192M
$145K 0.03%
6,288
– –
NVR icon
392
NVR
NVR
$17.1B
$144K 0.03%
+29
New +$141K
TT icon
393
Trane Technologies
TT
$98.8B
$144K 0.03%
780
+175
+29% +$31.2K
G icon
394
Genpact
G
$6.22B
$137K 0.02%
3,018
– –
ADUS icon
395
Addus HomeCare
ADUS
$2.22B
$133K 0.02%
1,528
– –
TER icon
396
Teradyne
TER
$50B
$132K 0.02%
985
– –
IRBT
397
DELISTED
iRobot
IRBT
$130K 0.02%
+1,391
New +$143K
PZZA icon
398
Papa John's
PZZA
$1.01B
$126K 0.02%
+1,203
New +$117K
STX icon
399
Seagate
STX
$173B
$125K 0.02%
+1,425
New +$128K
POOL icon
400
Pool Corp
POOL
$7.05B
$123K 0.02%
+269
New +$113K
14 15
16
17 18

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Globeflex Capital held 514 positions worth $557M, up 1.5% from $549M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Globeflex Capital withdrew a net $17.4M in Q2 2021, closing 62 positions and reducing 63 holdings. Its most notable exit was Perficient Inc, an estimated $1.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Globeflex Capital opened a new position in Ovid Therapeutics worth $3.95M.

  • Globeflex Capital's largest Q2 2021 buy was Ovid Therapeutics: 1,009,125 shares worth $3.95M.
  • Globeflex Capital added most to Amneal Pharmaceuticals in Q2 2021, an estimated $2.56M increase.
  • Globeflex Capital's biggest Q2 2021 reduction was Accendra Health, cutting an estimated $5.72M.
  • Globeflex Capital fully exited Perficient Inc in Q2 2021, selling an estimated $1.89M.
  • Globeflex Capital's ten largest holdings make up 16% of its $557M portfolio in Q2 2021.
  • Globeflex Capital opened 65 new positions and closed 62 in Q2 2021.
  • Globeflex Capital's portfolio value rose 1.5% quarter-over-quarter to $557M.

Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.